Recombinant Human Ccl28 Protein，His

Ccl28, also known as chemokine ligand 28, is a member of the CC chemokine family that plays a crucial role in immune response and inflammation. It is primarily expressed in mucosal tissues, including the gut and salivary glands, where it attracts immune cells to sites of infection and inflammation. Researchers have shown that Ccl28 is involved in recruiting specific subsets of T cells and memory B cells, thereby facilitating the development of an effective immune response in mucosal surfaces. Its importance is highlighted in various disease contexts, such as autoimmune disorders, allergies, and infections, where its expression may be upregulated. The recombinant Ccl28 protein has been produced for research purposes to better understand its biochemical properties and functional mechanisms. This protein enables scientists to explore Ccl28's therapeutic potential, including its application in vaccine development and treatment strategies targeting mucosal immunity. Fresh insights into Ccl28 signaling pathways may pave the way for novel interventions aimed at modulating immune responses, enhancing vaccine efficacy, or developing new therapeutic strategies for diseases that involve aberrant immune activation. The study of Ccl28 and its recombinant forms is crucial for advancing our understanding of mucosal immunology and could lead to significant breakthroughs in the management of various health conditions.